Hardt, Karin
Janssen (Belgium)
3 papers on CoChat
Most cited papers
- Verified
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., et al. (2021) · New England Journal of Medicine
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 2,397
- Verified
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women
Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet
Cervical Cancer and HPV ResearchReproductive tract infections research
Cited by 1,655
- Verified
Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults.
Hens, N., Habteab Ghebretinsae, A., Hardt, K., Van Damme, P., & Van Herck, K. (2014) · Vaccine
Hepatitis Viruses Studies and EpidemiologyHepatitis B Virus Studies
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free